• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者血浆外泌体的蛋白质组学分析

Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer.

作者信息

Bao Minwei, Huang Yuxia, Lang Zhongping, Zhao Hui, Saito Yuichi, Nagano Tatsuya, Kawagoe Izumi, Divisi Duilio, Hu Xiaoyi, Jiang Gening

机构信息

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

出版信息

Transl Lung Cancer Res. 2022 Jul;11(7):1434-1452. doi: 10.21037/tlcr-22-467.

DOI:10.21037/tlcr-22-467
PMID:35958340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359946/
Abstract

BACKGROUND

Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains unsatisfactory. This current study evaluated the relationship between histology of NSCLC and protein expression of exosomes in the plasma from NSCLC patients, and furthermore investigate the impact of the exosome profile on the tumor, node, metastasis (TNM) classification.

METHODS

Plasma samples were collected from 26 NSCLC patients before surgery. The exosomes were extracted from the plasma and liquid chromatography-mass spectrometry (LC/MS) was used to evaluate the expression of the proteins in the exosomes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using the Cytoscape 3.8.2 software. Multivariate logistic regression and receiver operating characteristic (ROC) curves were used to identify proteins which could effectively distinguish between lung adenocarcinoma and lung squamous cell carcinoma. The relationship between protein expression and the TNM stage was calculated using Spearman rank correlation.

RESULTS

The expression levels of ZSWIM9, FYB1, SERPINF1, C1orf68, MASP2, and IGHV3-72 were higher in patients with lung adenocarcinoma compared to patients with lung squamous cell carcinoma. MFGE8 was associated with the occurrence of squamous cell carcinoma. CORO1A was positively correlated with the TNM stage of the patients, and COL4A2 was negatively correlated with TNM stage. GO and KEGG analyses revealed that cholesterol metabolism was important in NSCLC development.

CONCLUSIONS

Lung adenocarcinoma may be distinguished from squamous cell carcinoma by the molecular profile of exosomes in the plasma samples. And, proteomics analysis suggested that cholesterol metabolism may play an important role of cancer progress in NSCLC.

摘要

背景

目前,非小细胞肺癌(NSCLC)患者的预后仍不尽人意。本研究评估了NSCLC的组织学与NSCLC患者血浆中外泌体蛋白表达之间的关系,并进一步研究了外泌体谱对肿瘤、淋巴结、转移(TNM)分期的影响。

方法

收集26例NSCLC患者术前的血浆样本。从血浆中提取外泌体,采用液相色谱-质谱联用(LC/MS)技术评估外泌体中蛋白质的表达。使用Cytoscape 3.8.2软件进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析。采用多因素逻辑回归和受试者工作特征(ROC)曲线来识别能够有效区分肺腺癌和肺鳞癌的蛋白质。使用Spearman等级相关性计算蛋白质表达与TNM分期之间的关系。

结果

与肺鳞癌患者相比,肺腺癌患者中ZSWIM9、FYB1、SERPINF1、C1orf68、MASP2和IGHV3-72的表达水平更高。MFGE8与鳞癌的发生有关。CORO1A与患者的TNM分期呈正相关,而COL4A2与TNM分期呈负相关。GO和KEGG分析表明,胆固醇代谢在NSCLC的发展中起重要作用。

结论

血浆样本中外泌体的分子谱可区分肺腺癌和肺鳞癌。而且,蛋白质组学分析表明,胆固醇代谢可能在NSCLC的癌症进展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/0e6c44d72d19/tlcr-11-07-1434-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/4d897a70bba0/tlcr-11-07-1434-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/f638303da423/tlcr-11-07-1434-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/2d6e8337f5e6/tlcr-11-07-1434-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/6b29c596680f/tlcr-11-07-1434-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/46ea9cfd097e/tlcr-11-07-1434-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/4d7e2907c6d1/tlcr-11-07-1434-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/05b681699679/tlcr-11-07-1434-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/0e6c44d72d19/tlcr-11-07-1434-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/4d897a70bba0/tlcr-11-07-1434-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/f638303da423/tlcr-11-07-1434-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/2d6e8337f5e6/tlcr-11-07-1434-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/6b29c596680f/tlcr-11-07-1434-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/46ea9cfd097e/tlcr-11-07-1434-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/4d7e2907c6d1/tlcr-11-07-1434-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/05b681699679/tlcr-11-07-1434-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/9359946/0e6c44d72d19/tlcr-11-07-1434-f9.jpg

相似文献

1
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer.非小细胞肺癌患者血浆外泌体的蛋白质组学分析
Transl Lung Cancer Res. 2022 Jul;11(7):1434-1452. doi: 10.21037/tlcr-22-467.
2
Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.非小细胞肺癌细胞中长链非编码RNA HOXA11-AS基因相互作用调控网络的综合分析
Cancer Cell Int. 2016 Dec 1;16:89. doi: 10.1186/s12935-016-0366-6. eCollection 2016.
3
Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.非小细胞肺癌中血浆外泌体Tim-3和半乳糖凝集素-9的表达谱及临床价值
Biochem Biophys Res Commun. 2018 Apr 6;498(3):409-415. doi: 10.1016/j.bbrc.2018.02.114. Epub 2018 Feb 13.
4
The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients.血清外泌体蛋白谱在非小细胞肺癌患者诊断中的比较。
Int J Mol Sci. 2023 Sep 5;24(18):13669. doi: 10.3390/ijms241813669.
5
A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.通过综合分析鉴定出一种在非小细胞肺癌中具有强大预测能力的新型缺氧相关基因特征。
Int J Genomics. 2022 May 19;2022:8594658. doi: 10.1155/2022/8594658. eCollection 2022.
6
[Diagnostic value of protein markers in plasma exosomes of lung squamous cell carcinoma].[蛋白质标志物在肺鳞状细胞癌血浆外泌体中的诊断价值]
Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):418-421. doi: 10.3760/cma.j.issn.0253-3766.2018.06.004.
7
Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.血浆 D-二聚体水平与非小细胞肺癌(NSCLC)患者的年龄、转移、复发、肿瘤-淋巴结-转移(TNM)分类和治疗相关。
Biomed Res Int. 2021 Oct 19;2021:9623571. doi: 10.1155/2021/9623571. eCollection 2021.
8
Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.桥粒芯蛋白2在肺腺癌中的上调及其临床价值:基于多种生物信息学方法的综合分析
PeerJ. 2020 Feb 13;8:e8420. doi: 10.7717/peerj.8420. eCollection 2020.
9
PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.PLA2G10 存在于外泌体中,可作为非小细胞肺癌的诊断和预后生物标志物。
Clin Chim Acta. 2022 May 1;530:55-65. doi: 10.1016/j.cca.2022.02.016. Epub 2022 Feb 26.
10
Plasma-derived exosomal immunoglobulins IGHV4-4 and IGLV1-40 as new non-small cell lung cancer biomarkers.血浆来源的外泌体免疫球蛋白IGHV4-4和IGLV1-40作为新型非小细胞肺癌生物标志物。
Am J Cancer Res. 2023 May 15;13(5):1923-1937. eCollection 2023.

引用本文的文献

1
Functional tumor-derived exosomes in NSCLC progression and clinical implications.功能性肿瘤来源外泌体在非小细胞肺癌进展中的作用及临床意义
Front Pharmacol. 2025 Mar 19;16:1485661. doi: 10.3389/fphar.2025.1485661. eCollection 2025.
2
Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development.胰腺囊肿液和血清中的多组学生物标志物 panel 可预测胰腺癌发生风险高的患者。 (注:这里“panel”结合语境大概可理解为“组合、指标体系”等意思,具体准确含义需结合更多背景信息确定)
Sci Rep. 2025 Jan 2;15(1):129. doi: 10.1038/s41598-024-83742-4.
3
Comparative proteomic analysis between tumor tissues and intratumoral exosomes from lung adenocarcinoma patients identifies PAFAH1B3 as an exosomal protein key for initiating metastasis in lung adenocarcinoma.

本文引用的文献

1
Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.单细胞测序鉴定肝癌 CD8+T 细胞异质性和新型生物标志物基因。
J Healthc Eng. 2022 Apr 12;2022:8256314. doi: 10.1155/2022/8256314. eCollection 2022.
2
Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.胆固醇通过诱导 EGFR/Src/Erk/SP1 信号介导的 ERRα 重新表达促进 NSCLC 对 EGFR-TKIs 的耐药性。
Mol Cancer. 2022 Mar 18;21(1):77. doi: 10.1186/s12943-022-01547-3.
3
Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and Cell Heterogeneity in the Microenvironment.
肺腺癌患者肿瘤组织与瘤内囊泡的比较蛋白质组学分析确定PAFAH1B3是肺腺癌中启动转移的关键囊泡蛋白。
Heliyon. 2024 Oct 28;10(21):e39859. doi: 10.1016/j.heliyon.2024.e39859. eCollection 2024 Nov 15.
4
Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing.基于单细胞RNA测序鉴定肺腺癌中与KRAS/TP53共突变状态相关的肿瘤异质性
Am J Cancer Res. 2024 Feb 15;14(2):655-678. doi: 10.62347/NXAJ9418. eCollection 2024.
5
AuNPs/CNC Nanocomposite with A "Dual Dispersion" Effect for LDI-TOF MS Analysis of Intact Proteins in NSCLC Serum Exosomes.具有“双重分散”效应的 AuNPs/CNC 纳米复合材料,用于 NSCLC 血清外泌体中完整蛋白质的 LDI-TOF MS 分析。
Adv Sci (Weinh). 2024 Mar;11(12):e2307360. doi: 10.1002/advs.202307360. Epub 2024 Jan 15.
6
Lactadherin immunoblockade in small extracellular vesicles inhibits sEV-mediated increase of pro-metastatic capacities.乳铁蛋白免疫阻断小细胞外囊泡抑制 sEV 介导的促转移能力增加。
Biol Res. 2024 Jan 3;57(1):1. doi: 10.1186/s40659-023-00477-8.
7
The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients.血清外泌体蛋白谱在非小细胞肺癌患者诊断中的比较。
Int J Mol Sci. 2023 Sep 5;24(18):13669. doi: 10.3390/ijms241813669.
8
Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment.转移性黑色素瘤患者中与泛素化相关的生物标志物及其在肿瘤微环境中的作用。
Front Oncol. 2023 May 19;13:1170190. doi: 10.3389/fonc.2023.1170190. eCollection 2023.
9
Proteomics analysis of serum from thymoma patients.胸腺瘤患者血清的蛋白质组学分析。
Sci Rep. 2023 Mar 29;13(1):5117. doi: 10.1038/s41598-023-32339-4.
10
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model.肺纤维化进展和博来霉素诱导的小鼠模型治疗反应的蛋白质组指纹图谱。
Int J Mol Sci. 2023 Feb 23;24(5):4410. doi: 10.3390/ijms24054410.
肝细胞癌的单细胞测序揭示了微环境中的细胞相互作用和细胞异质性。
Int J Gen Med. 2021 Dec 22;14:10141-10153. doi: 10.2147/IJGM.S338090. eCollection 2021.
4
Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells.肽纳米颗粒介导的癌症相关小干扰RNA组合递送用于三阴性乳腺癌细胞的协同抗增殖活性
Pharmaceuticals (Basel). 2021 Sep 23;14(10):957. doi: 10.3390/ph14100957.
5
Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer.自噬激活和质膜胆固醇减少有助于非小细胞肺癌的抗癌活性。
Molecules. 2021 Oct 1;26(19):5967. doi: 10.3390/molecules26195967.
6
Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.术前血清三酰甘油和高密度脂蛋白胆固醇对非小细胞肺癌患者预后的意义:一项回顾性研究。
Lipids Health Dis. 2021 Oct 2;20(1):69. doi: 10.1186/s12944-021-01492-y.
7
Identifying metabolic alterations in newly diagnosed small cell lung cancer patients.识别新诊断的小细胞肺癌患者的代谢改变。
Metabol Open. 2021 Sep 16;12:100127. doi: 10.1016/j.metop.2021.100127. eCollection 2021 Dec.
8
Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages.人肺癌组织和肿瘤相关巨噬细胞中胆固醇动态平衡的失调。
EBioMedicine. 2021 Oct;72:103578. doi: 10.1016/j.ebiom.2021.103578. Epub 2021 Sep 25.
9
Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.非小细胞肺癌中与吉非替尼获得性耐药相关的枢纽基因和小分子药物的鉴定
J Cancer. 2021 Jul 2;12(17):5286-5295. doi: 10.7150/jca.56506. eCollection 2021.
10
Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis.小细胞外囊泡中蛋白酶解和分泌导致 EMILIN-1 失活,有利于黑色素瘤的进展和转移。
Int J Mol Sci. 2021 Jul 9;22(14):7406. doi: 10.3390/ijms22147406.